NCT04310436

Brief Summary

This is a pilot randomised controlled trial investigating whether using modification of saccadic eye movements can control lateral unconscious tongue positioning and enhance fluency in adults with a confirmed developmental stammer. This study is being conducted as part of an MSc by research qualification at the Institute of Technology Sligo in Ireland with a view to extending to PhD. The setting is home setting with all assessments either taking place at home via video link or in the institute. The study is being conducted in conjunction with the Community Speech and Language Therapist and has attained ethical approval through Sligo University Hospital (SUH) Ethics Committee.

Trial Health

53
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial recruitment is currently suspended
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
16mo left

Started Mar 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Mar 2020Sep 2027

Study Start

First participant enrolled

March 10, 2020

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

March 13, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 17, 2020

Completed
6.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2026

Expected
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 2, 2027

Last Updated

October 26, 2024

Status Verified

October 1, 2024

Enrollment Period

6.8 years

First QC Date

March 13, 2020

Last Update Submit

October 23, 2024

Conditions

Keywords

NeuroplasticityEye saccadesUnconscious tongue movement

Outcome Measures

Primary Outcomes (1)

  • Stammering Severity (SSI-4) (Howell et. al. 2011).

    Measures stuttering severity in adults and children. It measures the percentage of stuttered syllables versus fluent speech in the participant. It also measures the frequency of repetition and prolongations, duration of blocks, and physical concomitants.

    10 minutes.

Secondary Outcomes (2)

  • Stammering Experience Overall Assessment of the Speaker's Experience of Stuttering OASES-A (Yaruss & Quesal 2006).

    10 minutes.

  • Premonitory Awareness in Stuttering Scale (PAiS) (Cholin et. al. 2016).

    10 minutes.

Study Arms (2)

Looking down to naval.

EXPERIMENTAL

Modifying Saccade origin by looking down to naval.

Behavioral: Modifying saccades by looking down to naval.

Looking up in the air.

PLACEBO COMPARATOR

Modifying Saccade origin by looking up in the air.

Behavioral: Modifying saccades by looking in air.

Interventions

Paragraphs from list Provided by Researcher. Participants to read out loud for 10 minutes twice per day for the five week period. On any word they anticipate / experience dysfluencies look quickly down to their naval to reset the lateral tongue position.

Looking down to naval.

Paragraphs from list provided by Researcher. Participants to read out loud for 10 minutes twice per day for the five week period. On any word they anticipate / experience dysfluencies look quickly up to reset the lateral tongue position.

Looking up in the air.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults age \> 18 years.
  • A diagnosis of confirmed developmental stammer from SALT characterized by stammering on ≥ 3% of syllables.
  • A proficiency in the English Language.
  • No diagnosis of any emotional, behavioural, learning or neurological disorder.
  • Cognitive ability to take part.
  • Have previously completed a course of outpatient treatment for confirmed developmental stammer.

You may not qualify if:

  • Younger than 18 years.
  • Not having completed a traditional intervention for stammer.
  • This research is not intended to replace current interventions but provide additional possibilities for those adults who have completed a standard programme of intervention and their developmental stammer still persists and a rate of ≥ 3% of syllables

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Technology, Sligo

Sligo, Co Sligo, F91YW50, Ireland

Location

MeSH Terms

Conditions

Stuttering

Interventions

Air

Condition Hierarchy (Ancestors)

Speech DisordersLanguage DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AtmosphereEnvironmentEcological and Environmental PhenomenaBiological PhenomenaMeteorological ConceptsEnvironment and Public Health

Study Officials

  • Hilary Mc Donagh, MSc

    Study Principal Investigator

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Experimental Group instructed to modify saccadic origin by looking to naval for the start of the words dysfluencies were predicted Placebo Group instructed to modify saccadic origin by looking up for the start of the words dysfluencies were predicted Outcome assessor was blinded to treatment allocation. Participants Stammering behaviour to be assessed using SSI-4 a reliable validated objective measure of stuttering severity. Participants stammering behaviour is to be recorded via video link or in a separate lab and the assessor will be asked asked not to discuss the technique prescribed given to patients. Even if the patient mentioned the trials they would not discuss the intervention
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Pilot Randomised Placebo Controlled Trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 13, 2020

First Posted

March 17, 2020

Study Start

March 10, 2020

Primary Completion (Estimated)

December 10, 2026

Study Completion (Estimated)

September 2, 2027

Last Updated

October 26, 2024

Record last verified: 2024-10

Locations